Who should take new Alzheimer`s drug? Expert weighs in
(Fox News Health)

After the Food and Drug Administration granted approval to the first Alzheimer`s drug in nearly two decades, Biogen`s Aduhelm (aducanumab), doctors are left triaging patient calls in a bid to find the appropriate patient with a mild, early course of disease.